Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job ...

BofA Securities 2025 Healthcare Conference May 14, 2025 1:00 PM ETCompany ParticipantsJeff Stewart - EVP and Chief ...

Pfizer Inc.’s stock rose handily Tuesday after the drug manufacturer said it’s trending toward the higher end of its 2025 profit projections. Pfizer also beat analyst expectations for first ...

President Trump and British Prime Minister Keir Starmer announced a new trade agreement. Other countries, including China, ...

The imposition of tariffs on pharmaceutical imports - either directly or indirectly through raw materials and active ...

BioNTech invites investors and the general public to join a conference call and webcast with investment analysts today, May 5, 2025, at 8:00 a.m. EDT (2:00 p.m. CEST) to report its financial results ...

Baxter International, a prominent health care and pharmaceutical manufacturer, reports that President Trump's tariffs will ...

Drugmaker executives have projected confidence they can mitigate the impact of any levies Trump imposes on the industry. Yet ...

Pfizer CEO Albert Bourla said the pharmaceutical ... the company behind fast food chains like Taco Bell and Pizza Hut, expects little impact from tariffs on its supply chain, CFO Chris Turner ...

According to the nonpartisan Penn Wharton Budget Model, which tracks weekly Treasury data, total spending rose by 6.3%, or $156 billion, since Donald Trump took office, compared to the first four ...

Pfizer's CEO said tariff uncertainty is hindering the company from making big investments in the US. Albery Bourla said there could be "tremendous investments" in R&D and manufacturing in the US.